Guangdong Marubi Biotechnology Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 382.67 million compared to CNY 404.12 million a year ago. Revenue was CNY 382.67 million compared to CNY 404.12 million a year ago. Net income was CNY 65.48 million compared to CNY 100.13 million a year ago. Basic earnings per share from continuing operations was CNY 0.16 compared to CNY 0.25 a year ago. Diluted earnings per share from continuing operations was CNY 0.16 compared to CNY 0.25 a year ago.